Kimialys

French tech company | Builders Republic

About

Industrial biosensing company supplying surface-chemistry technology to diagnostics and life-science labs — its K-One platform attaches molecules onto gold nanoparticles, chips and electrodes to enable sensitive detection, used to develop rapid tests, lateral-flow assays and antibody-screening tools.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Series A
Founded
2020
City
PARIS
Region
IDF
Tracked rounds
2
Amount raised
4.5 M€ raised since 2020

Funding rounds

  • Series A — 2025
  • Seed — 2023

Investors